Reeve Bryce B, McFatrich Molly, Pinheiro Laura C, Weaver Meaghann S, Sung Lillian, Withycombe Janice S, Baker Justin N, Mack Jennifer W, Waldron Mia K, Gibson Deborah, Tomlinson Deborah, Freyer David R, Mowbray Catriona, Jacobs Shana, Palma Diana, Martens Christa E, Gold Stuart H, Jackson Kathryn D, Hinds Pamela S
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26261. Epub 2016 Sep 21.
Adverse event (AE) reporting in oncology trials is required, but current practice does not directly integrate the child's voice. The Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is being developed to assess symptomatic AEs via child/adolescent self-report or proxy-report. This qualitative study evaluates the child's/adolescent's understanding and ability to provide valid responses to the PRO-CTCAE to inform questionnaire refinements and confirm content validity.
From seven pediatric research hospitals, children/adolescents ages 7-15 years who were diagnosed with cancer and receiving treatment were eligible, along with their parent-proxies. The Pediatric PRO-CTCAE includes 130 questions that assess 62 symptomatic AEs capturing symptom frequency, severity, interference, or presence. Cognitive interviews with retrospective probing were completed with children in the age groups of 7-8, 9-12, and 13-15 years. The children/adolescents and proxies were interviewed independently.
Two rounds of interviews involved 81 children and adolescents and 74 parent-proxies. Fifteen of the 62 AE terms were revised after Round 1, including refinements to the questions assessing symptom severity. Most participants rated the PRO-CTCAE AE items as "very easy" or "somewhat easy" and were able to read, understand, and provide valid responses to questions. A few AE items assessing rare events were challenging to understand.
The Pediatric and Proxy PRO-CTCAE performed well among children and adolescents and their proxies, supporting its content validity. Data from PRO-CTCAE may improve symptomatic AE reporting in clinical trials and enhance the quality of care that children receive.
肿瘤学试验中需要报告不良事件(AE),但目前的做法并未直接纳入儿童的意见。正在开发儿童患者报告结果版的不良事件通用术语标准(PRO-CTCAE),以通过儿童/青少年自我报告或代理报告来评估有症状的不良事件。这项定性研究评估了儿童/青少年对PRO-CTCAE的理解以及提供有效回答的能力,以为问卷完善提供信息并确认内容效度。
从七家儿科研究医院招募了年龄在7至15岁、被诊断患有癌症并正在接受治疗的儿童/青少年及其家长代理。儿科PRO-CTCAE包括130个问题,用于评估62种有症状的不良事件,涵盖症状频率、严重程度、干扰或存在情况。对7至8岁、9至12岁和13至15岁年龄组的儿童进行了带有回顾性探查的认知访谈。儿童/青少年和代理分别接受访谈。
两轮访谈涉及81名儿童和青少年以及74名家长代理。第一轮访谈后,62个AE术语中有15个进行了修订,包括对评估症状严重程度问题的细化。大多数参与者将PRO-CTCAE的AE项目评为“非常容易”或“有点容易”,并且能够阅读、理解并对问题提供有效回答。一些评估罕见事件的AE项目理解起来具有挑战性。
儿科及代理版PRO-CTCAE在儿童、青少年及其代理中表现良好,支持其内容效度。PRO-CTCAE的数据可能会改善临床试验中有症状AE的报告,并提高儿童接受的护理质量。